Multiple sclerosis is not a genetic disorder in the traditional sense. Unlike conditions such as cystic fibrosis or sickle cell disease, where a single gene mutation directly causes the disease, MS results from a complex interaction between genetic susceptibility and environmental triggers. Genetics account for roughly half the risk, with environmental factors making up the other half. This means you can carry every known risk gene and never develop MS, or you can develop it with a relatively modest genetic profile if the right environmental exposures line up.
Why MS Is Called a Complex Disease
A true genetic disorder follows a predictable inheritance pattern. One or two gene mutations are enough to cause it, and if you carry those mutations, you will almost certainly develop the condition. MS doesn’t work this way. Instead, it’s classified as a complex, multifactorial disease, meaning dozens or even hundreds of small genetic variations each contribute a tiny nudge toward increased risk, and environmental factors push things the rest of the way.
Genome-wide association studies involving over 20,000 people with MS and more than 700,000 controls have identified 236 genetic variants outside the major immune-gene region that independently affect MS susceptibility. No single variant is enough to cause the disease on its own. Each one slightly alters how the immune system functions, and together they create a landscape of vulnerability rather than a guaranteed outcome.
The Strongest Genetic Risk Factor
One region of the genome stands out above all others. A set of immune system genes known as the HLA-DR15 haplotype may account for up to 60% of the total genetic risk for MS. These genes control how your immune cells recognize threats. In people who carry this variant, immune cells may be more prone to mistakenly targeting the body’s own nerve insulation, the hallmark of MS.
The mechanism isn’t fully understood, but research suggests the DR15 variant shapes the development of immune cells in ways that make them more reactive to the body’s own tissues. It may allow certain self-attacking immune cells to survive when they would normally be eliminated, and it may cause immune cells to present the body’s own proteins as if they were foreign invaders. Still, many people carry this variant and never develop MS, which underscores how much the environment matters.
How Much Risk Runs in Families
Family studies offer the clearest picture of how genetics influence MS risk. In the general population, roughly 1 in 1,000 people develops the disease. For siblings of someone with MS, that risk rises to about 2.9%, or roughly 1 in 34. For identical twins, who share virtually all their DNA, the concordance rate is about 25%. Among female identical twin pairs, it climbs to 34%.
That 25% figure is telling. If MS were purely genetic, identical twins would almost always share the diagnosis. Instead, three out of four identical twins of someone with MS never develop the condition themselves. This gap is strong evidence that genes set the stage but don’t write the script.
Does It Matter Which Parent Has MS?
Interestingly, the risk isn’t equal depending on which parent is affected. Fathers with MS transmit the disease to their children about twice as often as mothers with MS do. This pattern, known as the Carter effect, likely reflects the fact that men are naturally less susceptible to MS (the disease is roughly twice as common in women). A man who develops MS despite that lower baseline susceptibility probably carries a heavier genetic load, which he then passes on to his children at higher rates.
Environmental Triggers That Activate Genetic Risk
Carrying MS risk genes is like having dry kindling. Environmental factors provide the spark. Two stand out above the rest: infection with Epstein-Barr virus (the virus that causes mono) and low vitamin D levels.
About 90% of the global population carries Epstein-Barr virus, yet only a tiny fraction develops MS. This means the virus alone isn’t sufficient. But in genetically predisposed individuals, the combination is potent. Studies show that carrying both the HLA-DRB1*15:01 gene variant and a history of Epstein-Barr infection creates a stronger association with MS than either factor alone. The effects appear to be additive: each risk factor layers on top of the others.
Vitamin D plays a particularly interesting role because it directly interacts with MS-associated genes. Vitamin D response elements are present in the regulatory regions of more than 80% of known MS susceptibility genes. When vitamin D levels are low, the expression of those genes can shift in ways that favor immune dysfunction. Low vitamin D also appears to weaken the body’s ability to keep Epstein-Barr virus in check, potentially allowing infected cells to spread and further provoke an already vulnerable immune system.
Smoking and exposure to organic solvents are additional environmental risk factors, though their individual contributions are smaller than those of Epstein-Barr virus and vitamin D deficiency.
Ancient Origins of MS Risk Genes
A striking finding published in Nature in 2024 traced many MS risk genes back thousands of years to steppe pastoralist populations who migrated into Europe around 5,000 years ago. These nomadic herders lived in close contact with livestock and faced a different set of infectious threats than the farming communities already living in Europe. The immune gene variants that helped them survive those infections are the same variants that increase MS risk today.
This evolutionary history helps explain why MS is far more common in people of Northern European descent. It also means that MS risk genes weren’t random mutations that slipped through. They were actively favored by natural selection because they provided survival advantages in specific ancient environments. The trade-off is a modern immune system that, in certain people under certain conditions, turns against itself.
Can Genetic Testing Predict MS?
Given that over 230 genetic variants contribute to MS risk and none of them is individually decisive, genetic testing is not a standard part of MS diagnosis or risk prediction. Carrying the highest-risk gene variant (HLA-DR15) is common in the general population, and most carriers never develop the disease. There is currently no genetic test that can reliably tell you whether you will or won’t get MS.
MS is diagnosed through a combination of clinical symptoms, MRI imaging of the brain and spinal cord, and sometimes spinal fluid analysis. If you have a family member with MS, your absolute risk is still relatively low. A sibling’s risk of about 3% means a 97% chance of not developing the condition. Even for identical twins, the odds favor staying unaffected.
The bottom line is that MS has a significant genetic component, but calling it a genetic disorder overstates the role of DNA and understates the environmental half of the equation. It is a disease of genetic susceptibility, where inherited immune system traits interact with viral infections, vitamin D status, and other exposures to determine whether the disease ever appears.